SCHEMBL7974253

SCHEMBL7974253

CCCc1nc2ncn(Cc3ccncc3)c2c(=O)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
CNOT7 Q9UIV1 1/20 0.46
KMT2A Q03164 1/20 0.45
KDM4C Q9H3R0 1/20 0.44
KDM4E B2RXH2 5/20 0.39
HSD17B10 Q99714 1/20 0.39
TYMS P04818 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
BRD4 O60885 3/20 0.38
MAPK1 P28482 1/20 0.37
BRD2 P25440 1/20 0.37
BRD3 Q15059 1/20 0.37
BRDT Q58F21 1/20 0.37
RXFP1 Q9HBX9 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989405 0.89 SMN1; SMN2 (0.57) HPGDALDH1A1SMN1; SMN2CNOT7KMT2A
SCHEMBL7989373 0.88 HPGD (0.46) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7988953 0.87 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL7985859 0.86 CNOT7 (0.49) HPGDALDH1A1SMN1; SMN2CNOT7KMT2A
SCHEMBL7984742 0.85 ABCC8 (0.48) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7985729 0.84 HPGD (0.50) HPGDALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL7991723 0.83 SMN1; SMN2 (0.49) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7987608 0.82 SMN1; SMN2 (0.55) HPGDALDH1A1SMN1; SMN2CNOT7KMT2A
SCHEMBL7988657 0.82 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2AHSD17B10
SCHEMBL7974110 0.81 CNOT7 (0.47) HPGDALDH1A1SMN1; SMN2CNOT7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed